Istanbul nightclub attack kills 39 in New Year carnage

January 1, 2017

Istanbul, Jan 1: Thirty-nine people, including many foreigners, were killed when a gunman reportedly dressed as Santa Claus stormed an Istanbul nightclub as revellers were celebrating the New Year, the latest carnage to rock Turkey after a bloody 2016.

Istanbul

The assailant shot dead a policeman and a civilian at the entrance to the Reina club, one of the city's most exclusive nightspots, and then went on a shooting rampage inside, Turkish officials said.

Interior Minister Suleyman Soylu said the attacker escaped and was now the target of a major manhunt, expressing hope the suspect "would be captured soon".

Soylu said in televised comments that of 21 victims who have been identified so far, 16 are foreigners and five are Turks. Another 69 people are being treated in hospital.

"The attacker - in the most brutal and merciless way - targeted innocent people who had only come here to celebrate the New Year and have fun," Istanbul governor Vasip Sahin said at the scene on the shores of the Bosphorus.

Many revellers threw themselves into the water in panic and efforts were under way to rescue them, NTV television said.

Dogan news agency said there were two gunmen dressed in Santa Claus outfits, although this has yet to be confirmed.

Television pictures showed party-goers - including men in suits and women in cocktail dresses - emerging from the nightclub in a state of shock.

Sahin said the attack began at 1:15 am today (local time), just after hundreds of revellers had seen in 2017 at the club in the Ortakoy district on the European side of the city.

"What happened today is a terror attack," he said.

Dogan reported that some witnesses claimed the assailants were "speaking Arabic" while NTV said special force police officers were still searching the club.

There has been no claim of responsibility.

The attack evoked memories of the November 2015 carnage in Paris when Islamic State jihadists went on a gun and bombing rampage on nightspots in the French capital, killing 130 people including 90 at the Bataclan concert hall.

From Sydney to Paris, Rio to London, security had been boosted over fears that the New Year festivities could present a target for violent extremists.

In Istanbul, at least 17,000 police officers were deployed and some, as is customary in Turkey, dressed themselves as Santa Claus as cover, according to television reports.

"Just as we were settling down, by the door there was a lot of dust and smoke. Gunshots rang out. When those sounds were heard, many girls fainted," professional footballer Sefa Boydas told AFP.

"They say 35 to 40 died but it's probably more because when I was walking, people were walking on top of people."

Dogan said there were at least 700 revellers at the elite club, where getting past the bouncers who seek out only the best dressed is notoriously hard.

Turkey has been hit by a wave of attacks blamed on Kurdish militants and IS jihadists and 2016 saw more attacks than any other year in the history of the country.

On December 10, 44 people were killed in a double bombing in Istanbul after a football match hosted by top side Besiktas, an attack claimed by the Kurdistan Freedom Falcons (TAK) seen as a radical offshoot of the outlawed PKK rebel group.

In June, 47 people were killed in a triple suicide bombing and gun attack at Istanbul's Ataturk airport, with authorities blaming IS.

And in one of the most brazen strikes, an off-duty policeman assassinated Russia's ambassador to Turkey in an Ankara art gallery less than two weeks ago.

"No terror attack will destroy our unity, or eradicate our fraternity or weaken Turkey's effective fight against terror," Justice Minister Bekir Bozdag wrote on Twitter.

Mainly Muslin Turkey's religious affairs agency Diyanet condemned the attack, saying the fact it took place in a nightclub "was no different to it being in a market or place of worship".

Turkey is still reeling from a failed July coup blamed by the government on the US-based Islamic preacher Fethullah Gulen that has been followed by a relentless purge of his alleged supporters from state institutions.

"Tragic start to 2017 in Istanbul," NATO Secretary General Jens Stoltenberg wrote on Twitter.

The White House condemned the "savagery" of the attack, with National Security Council spokesman Ned Price saying that Washington reaffirmed its support for its NATO ally "in our shared determination to confront and defeat all forms of terrorism".

The US embassy warned citizens that extremist groups are continuing "aggressive efforts to conduct attacks in areas where US citizens and expatriates reside or frequent."

Turkish President Recep Tayyip Erdogan, who is in Istanbul for the New Year, had been informed of the attack, local media said.

The shooting spree came as the Turkish army wages a four-month incursion in Syria to oust IS jihadists and Kurdish militants from the border area, suffering increasing casualties.

As is customary after such attacks in Turkey, the authorities slapped a broadcast ban on images from the incident.

Comments

Naren kotian
 - 
Sunday, 1 Jan 2017

Israel actions are totally justified ...democracies must understand how to deal with jihadist menace ...religion of piece ....while shooting ...attacker shouting religious slogans. . time has come to mercilessly attack ...bomb them ...sympathy torsidre bennige chaaku haako jana...death to Islamic state ....rip innocents party goers.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 20,2020

May 20: The novel coronavirus is behaving differently in patients in northeast China who have contracted it recently compared with early cases, indicating it is changing as it spreads, a prominent doctor said.

China, which has largely brought the virus under control, has found new clusters of infections in the northeastern border provinces of Jilin and Heilongjiang in recent weeks, raising concern about a second wave.

Qiu Haibo, an expert in critical care medicine who is part of a National Health Commission expert group, said the incubation period of the virus in patients in the northeast was longer than that of patients in Wuhan, the central city, where the virus emerged late last year.

COVID-19 Pandemic Tracker: 15 countries with the highest number of coronavirus cases, deaths

"This causes a problem, as they don't have any symptoms. So when they gather with their families they don't care about this issue and we see family cluster infections," Qiu told state broadcaster CCTV in a programme broadcast late on Tuesday.

Patients in the northeastern clusters were also carrying the virus for longer than earlier cases in Wuhan, and they were taking longer to recover, as defined by a negative nucleic acid test, he said.

Patients in the northeast also rarely exhibited fever and tended to suffer damage to the lungs rather than across multiple organs, he said.

He said the virus found in the northeastern clusters was probably imported from abroad, which could account for the differences.

He did not say where he though they might have come from but both Jilin and Heilongjiang border Russia.

China reported five new coronavirus cases on Wednesday, down from six a day earlier.

Four of the new cases were local transmissions and one was imported by a traveller coming from abroad, the commission said in a statement, compared with three imported cases reported the previous day.

China's total number of coronavirus infections stands at 82,965, while the death toll 4,634. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.